SYNCOM FORMULATIONS (INDIA)
Back to Income Statement
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Profit Before Tax History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2017 | |
|---|---|---|---|---|---|
| Profit Before Tax | ₹34 Cr | ₹27 Cr | ₹26 Cr | ₹1,587,742 Cr | ₹16 Cr |
What is the latest Profit Before Tax of SYNCOM FORMULATIONS (INDIA) ?
| Year | Profit Before Tax |
|---|---|
| Mar2025 | ₹34 Cr |
| Mar2024 | ₹27 Cr |
| Mar2023 | ₹26 Cr |
| Mar2022 | ₹1,587,742 Cr |
| Mar2017 | ₹16 Cr |
How is Profit Before Tax of SYNCOM FORMULATIONS (INDIA) Trending?
| Years | Profit Before Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹34 Cr | 27.77 | |
| Mar2024 | ₹27 Cr | 1.52 | |
| Mar2023 | ₹26 Cr | -100.00 | |
| Mar2022 | ₹1,587,742 Cr | 9,861,041.23 | |
| Mar2017 | ₹16 Cr | - | |
Compare Profit Before Tax of peers of SYNCOM FORMULATIONS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYNCOM FORMULATIONS (INDIA) | ₹1,343.3 Cr | 1% | 3.9% | -33.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,620.0 Cr | 1% | -0.9% | 6.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,087.0 Cr | 1.8% | -2.3% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹154,837.0 Cr | 3.7% | 6.5% | 44.9% | Stock Analytics | |
| CIPLA | ₹112,194.0 Cr | 0% | 4.7% | -8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,328.0 Cr | -0.2% | 0.7% | -3.4% | Stock Analytics | |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYNCOM FORMULATIONS (INDIA) | 1% |
3.9% |
-33.1% |
| SENSEX | 1.7% |
1.3% |
-7.3% |
You may also like the below Video Courses